Skip to main content
. 2023 Oct 12;9(12):1660–1668. doi: 10.1001/jamaoncol.2023.4015

Figure 2. Local Control After Intratumoral Glycopyranosyl Lipid A in Stable-Emulsion Formulation (IT GLA-SE) Compared With Concomitant Lesions.

Figure 2.

A, Percent change in size of lesions at end of same follow-up period for tumors receiving IT GLA-SE plus radiotherapy (orange) vs tumors receiving radiation only (blue) or no local treatment (green). B, Representative computed tomograms of lesions at baseline and at last follow-up in a patient with undifferentiated round cell sarcoma and complete regression of tumor after IT GLA-SE and patient with leiomyosarcoma −79% in size after IT GLA-SE.